Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT04564755
What this trial is testing

Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT03831191
What this trial is testing

LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 136
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07734415
What this trial is testing

Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopic Dermatitis EczemaEczema
Inmagene LLC 400
Not applicableStudy completedNCT00148746
What this trial is testing

Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Technische Universität Dresden
Testing effectiveness (Phase 2)Looking for participantsNCT07216027
What this trial is testing

Learn About Study Medicine Called PF-08049820 in People With Eczema

Who this might be right for
Atopic DermatitisEczema, Atopic
Pfizer 165
Not applicableUnknownNCT03458624
What this trial is testing

Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 14
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Large-scale testing (Phase 3)Study completedNCT03160885
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Who this might be right for
Atopic Dermatitis
LEO Pharma 794
Early research (Phase 1)Study completedNCT04271514
What this trial is testing

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 103
Large-scale testing (Phase 3)Not Yet RecruitingNCT07762833
What this trial is testing

Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Galderma R&D 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT07377838
What this trial is testing

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 286
Testing effectiveness (Phase 2)Study completedNCT05014438
What this trial is testing

BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bristol-Myers Squibb 17
Testing effectiveness (Phase 2)Ended earlyNCT03055195
What this trial is testing

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 34
Not applicableLooking for participantsNCT05689151
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic DermatitisEczema
Pfizer 183
Testing effectiveness (Phase 2)Study completedNCT05158023
What this trial is testing

Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
ASLAN Pharmaceuticals 302
Not applicableNot Yet RecruitingNCT04730024
What this trial is testing

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 102
Large-scale testing (Phase 3)Study completedNCT06277245
What this trial is testing

LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Lynk Pharmaceuticals Co., Ltd 356
Early research (Phase 1)Looking for participantsNCT06946641
What this trial is testing

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)
Shanghai Qilu Pharmaceutical Research and Development Center LTD 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT06863961
What this trial is testing

Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hoffmann-La Roche 162
Testing effectiveness (Phase 2)Ended earlyNCT04605094
What this trial is testing

Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AstraZeneca 194
Next Page